US Stock MarketDetailed Quotes

Teva Pharmaceutical Industries (TEVA)

Watchlist

34.290
-1.020-2.89%

Close May 15 15:59 ET

33.890
-0.400-1.17%

Post 20:01 ET

39.93BMarket Cap25.59P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Teva Pharmaceutical Industries (TEVA) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2026

(FY)Dec 31, 2025

(Q4)Dec 31, 2025

(Q3)Sep 30, 2025

(Q2)Jun 30, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q4)Dec 31, 2024

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

Total revenue

2.31%3.98B

4.31%17.26B

11.40%4.71B

3.42%4.48B

0.29%4.18B

1.89%3.89B

4.41%16.54B

-5.12%4.23B

12.52%4.33B

7.40%4.16B

Operating revenue

0.24%3.82B

6.55%16.83B

18.52%4.6B

4.78%4.36B

0.02%4.06B

3.16%3.82B

3.43%15.8B

-7.66%3.88B

11.44%4.16B

7.61%4.06B

Cost of revenue

-0.15%2.01B

-1.90%8.32B

-2.51%2.06B

-0.32%2.18B

-3.08%2.07B

-1.66%2.01B

3.43%8.48B

3.33%2.11B

9.20%2.18B

2.79%2.14B

Gross profit

5.06%1.97B

10.84%8.94B

25.22%2.66B

7.26%2.3B

3.85%2.1B

5.99%1.88B

5.48%8.06B

-12.17%2.12B

16.05%2.15B

12.69%2.02B

Operating expense

3.59%1.21B

6.09%4.99B

15.68%1.39B

5.58%1.23B

-0.41%1.2B

3.72%1.17B

5.59%4.7B

6.20%1.2B

6.11%1.16B

5.04%1.21B

Selling and administrative expenses

8.81%1B

7.32%3.97B

17.65%1.12B

5.30%973M

2.13%959M

3.72%919M

5.83%3.7B

5.54%952M

9.48%924M

3.19%939M

-Selling and marketing expense

11.90%696M

5.71%2.69B

15.85%753M

4.79%656M

-0.30%654M

2.30%622M

8.78%2.54B

6.56%650M

8.68%626M

8.79%656M

-General and administrative expense

2.36%304M

10.85%1.29B

21.52%367M

6.38%317M

7.77%305M

6.83%297M

-0.09%1.16B

3.42%302M

11.19%298M

-7.82%283M

Research and development costs

-10.12%222M

1.50%1.01B

8.10%267M

6.67%256M

-9.29%244M

2.07%247M

4.72%998M

8.81%247M

-5.14%240M

12.08%269M

Other operating expenses

-280.00%-9M

----

400.00%5M

----

Operating profit

7.51%759M

17.48%3.95B

37.64%1.27B

9.25%1.08B

10.17%899M

9.97%706M

5.32%3.36B

-28.30%922M

30.50%984M

26.32%816M

Net non-operating interest income expense

4.00%-216M

6.19%-985M

5.57%-271M

12.87%-237M

-4.56%-252M

10.00%-225M

4.11%-1.05B

0.00%-287M

2.86%-272M

10.07%-241M

Non-operating interest expense

-5.19%201M

-8.58%916M

-6.11%292M

-7.11%209M

-12.88%203M

-15.20%212M

-2.62%1B

40.72%311M

-19.64%225M

-13.06%233M

Total other finance cost

15.38%15M

43.75%69M

12.50%-21M

-40.43%28M

512.50%49M

--13M

-27.27%48M

---24M

--47M

--8M

Other net income (expense)

42.47%-107M

51.57%-1.74B

-3.85%-916M

81.22%-194M

45.99%-444M

78.35%-186M

-32.10%-3.6B

-78.90%-882M

-152.57%-1.03B

36.77%-822M

Gain on sale of security

----

-26.09%51M

----

81.58%69M

----

Special income (charges)

40.96%-111M

51.20%-1.79B

-6.72%-985M

82.53%-184M

46.66%-439M

78.56%-188M

-33.58%-3.68B

-84.60%-923M

-153.13%-1.05B

37.84%-823M

-Less：Restructuring and merger&acquisition

20.00%30M

-25.99%279M

85.00%37M

-18.18%45M

-17.62%173M

-72.83%25M

-42.79%377M

-95.31%20M

1.85%55M

138.64%210M

-Less:Impairment of capital assets

-88.31%9M

-59.77%1.03B

-3.01%773M

-85.58%79M

-81.13%100M

-88.66%77M

137.01%2.56B

1,072.06%797M

1,041.67%548M

-31.52%530M

-Less:Other special charges

-16.28%72M

-38.63%467M

26.02%155M

-86.67%60M

100.00%166M

-18.87%86M

-27.04%761M

261.76%123M

43.31%450M

-82.03%83M

-Gain on sale of business

----

-246.67%-22M

----

400.00%15M

----

-Gain on sale of property,plant,equipment

----

0.00%2M

----

-92.00%2M

----

Other non- operating income (expenses)

100.00%4M

-90.00%1M

164.29%18M

-150.00%-10M

-600.00%-5M

-88.89%2M

211.11%10M

9.68%-28M

185.71%20M

-95.83%1M

Income before tax

48.64%437M

195.25%1.22B

132.39%80M

299.38%646M

182.52%203M

162.96%294M

-105.77%-1.28B

-148.72%-247M

-606.25%-324M

73.35%-246M

Income tax

-9.46%67M

-126.63%-180M

-1,492.86%-390M

210.14%214M

-112.38%-78M

242.31%74M

9,757.14%676M

-31.71%28M

675.00%69M

4,037.50%630M

Earnings from equity interest net of tax

---1M

1,400.00%15M

--11M

-33.33%2M

-50.00%1M

----

-50.00%1M

--0

--3M

100.00%2M

Net income

67.73%369M

172.38%1.42B

274.91%481M

211.28%434M

132.38%283M

152.51%220M

-218.54%-1.96B

-158.89%-275M

-606.49%-390M

3.53%-874M

Net income continuous Operations

67.73%369M

172.38%1.42B

274.91%481M

211.28%434M

132.27%282M

152.51%220M

-218.54%-1.96B

-158.89%-275M

-613.16%-390M

3.53%-874M

Minority interest income

102.19%7M

-97.87%1M

102.14%6M

-471.43%-320M

-1,550.00%-58M

487.50%47M

17.14%-29M

Net income attributable to the parent company

72.43%369M

186.03%1.41B

321.20%480M

199.08%433M

133.33%282M

253.96%214M

-193.20%-1.64B

-146.87%-217M

-733.33%-437M

2.98%-846M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

72.43%369M

186.03%1.41B

321.20%480M

199.08%433M

133.33%282M

253.96%214M

-193.20%-1.64B

-146.87%-217M

-733.33%-437M

2.98%-846M

Basic earnings per share

68.42%0.32

184.83%1.23

321.05%0.42

197.44%0.38

133.33%0.25

258.33%0.19

-190.00%-1.45

-146.34%-0.19

-750.00%-0.39

3.85%-0.75

Diluted earnings per share

72.22%0.31

183.45%1.21

315.79%0.41

194.87%0.37

132.00%0.24

250.00%0.18

-190.00%-1.45

-146.34%-0.19

-750.00%-0.39

3.85%-0.75

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2026	(FY)Dec 31, 2025	(Q4)Dec 31, 2025	(Q3)Sep 30, 2025	(Q2)Jun 30, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q4)Dec 31, 2024	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024
Total revenue	2.31%3.98B	4.31%17.26B	11.40%4.71B	3.42%4.48B	0.29%4.18B	1.89%3.89B	4.41%16.54B	-5.12%4.23B	12.52%4.33B	7.40%4.16B
Operating revenue	0.24%3.82B	6.55%16.83B	18.52%4.6B	4.78%4.36B	0.02%4.06B	3.16%3.82B	3.43%15.8B	-7.66%3.88B	11.44%4.16B	7.61%4.06B
Cost of revenue	-0.15%2.01B	-1.90%8.32B	-2.51%2.06B	-0.32%2.18B	-3.08%2.07B	-1.66%2.01B	3.43%8.48B	3.33%2.11B	9.20%2.18B	2.79%2.14B
Gross profit	5.06%1.97B	10.84%8.94B	25.22%2.66B	7.26%2.3B	3.85%2.1B	5.99%1.88B	5.48%8.06B	-12.17%2.12B	16.05%2.15B	12.69%2.02B
Operating expense	3.59%1.21B	6.09%4.99B	15.68%1.39B	5.58%1.23B	-0.41%1.2B	3.72%1.17B	5.59%4.7B	6.20%1.2B	6.11%1.16B	5.04%1.21B
Selling and administrative expenses	8.81%1B	7.32%3.97B	17.65%1.12B	5.30%973M	2.13%959M	3.72%919M	5.83%3.7B	5.54%952M	9.48%924M	3.19%939M
-Selling and marketing expense	11.90%696M	5.71%2.69B	15.85%753M	4.79%656M	-0.30%654M	2.30%622M	8.78%2.54B	6.56%650M	8.68%626M	8.79%656M
-General and administrative expense	2.36%304M	10.85%1.29B	21.52%367M	6.38%317M	7.77%305M	6.83%297M	-0.09%1.16B	3.42%302M	11.19%298M	-7.82%283M
Research and development costs	-10.12%222M	1.50%1.01B	8.10%267M	6.67%256M	-9.29%244M	2.07%247M	4.72%998M	8.81%247M	-5.14%240M	12.08%269M
Other operating expenses	-280.00%-9M	----	----	----	----	400.00%5M	----	----	----	----
Operating profit	7.51%759M	17.48%3.95B	37.64%1.27B	9.25%1.08B	10.17%899M	9.97%706M	5.32%3.36B	-28.30%922M	30.50%984M	26.32%816M
Net non-operating interest income expense	4.00%-216M	6.19%-985M	5.57%-271M	12.87%-237M	-4.56%-252M	10.00%-225M	4.11%-1.05B	0.00%-287M	2.86%-272M	10.07%-241M
Non-operating interest expense	-5.19%201M	-8.58%916M	-6.11%292M	-7.11%209M	-12.88%203M	-15.20%212M	-2.62%1B	40.72%311M	-19.64%225M	-13.06%233M
Total other finance cost	15.38%15M	43.75%69M	12.50%-21M	-40.43%28M	512.50%49M	--13M	-27.27%48M	---24M	--47M	--8M
Other net income (expense)	42.47%-107M	51.57%-1.74B	-3.85%-916M	81.22%-194M	45.99%-444M	78.35%-186M	-32.10%-3.6B	-78.90%-882M	-152.57%-1.03B	36.77%-822M
Gain on sale of security	----	-26.09%51M	----	----	----	----	81.58%69M	----	----	----
Special income (charges)	40.96%-111M	51.20%-1.79B	-6.72%-985M	82.53%-184M	46.66%-439M	78.56%-188M	-33.58%-3.68B	-84.60%-923M	-153.13%-1.05B	37.84%-823M
-Less：Restructuring and merger&acquisition	20.00%30M	-25.99%279M	85.00%37M	-18.18%45M	-17.62%173M	-72.83%25M	-42.79%377M	-95.31%20M	1.85%55M	138.64%210M
-Less:Impairment of capital assets	-88.31%9M	-59.77%1.03B	-3.01%773M	-85.58%79M	-81.13%100M	-88.66%77M	137.01%2.56B	1,072.06%797M	1,041.67%548M	-31.52%530M
-Less:Other special charges	-16.28%72M	-38.63%467M	26.02%155M	-86.67%60M	100.00%166M	-18.87%86M	-27.04%761M	261.76%123M	43.31%450M	-82.03%83M
-Gain on sale of business	----	-246.67%-22M	----	----	----	----	400.00%15M	----	----	----
-Gain on sale of property,plant,equipment	----	0.00%2M	----	----	----	----	-92.00%2M	----	----	----
Other non- operating income (expenses)	100.00%4M	-90.00%1M	164.29%18M	-150.00%-10M	-600.00%-5M	-88.89%2M	211.11%10M	9.68%-28M	185.71%20M	-95.83%1M
Income before tax	48.64%437M	195.25%1.22B	132.39%80M	299.38%646M	182.52%203M	162.96%294M	-105.77%-1.28B	-148.72%-247M	-606.25%-324M	73.35%-246M
Income tax	-9.46%67M	-126.63%-180M	-1,492.86%-390M	210.14%214M	-112.38%-78M	242.31%74M	9,757.14%676M	-31.71%28M	675.00%69M	4,037.50%630M
Earnings from equity interest net of tax	---1M	1,400.00%15M	--11M	-33.33%2M	-50.00%1M	----	-50.00%1M	--0	--3M	100.00%2M
Net income	67.73%369M	172.38%1.42B	274.91%481M	211.28%434M	132.38%283M	152.51%220M	-218.54%-1.96B	-158.89%-275M	-606.49%-390M	3.53%-874M
Net income continuous Operations	67.73%369M	172.38%1.42B	274.91%481M	211.28%434M	132.27%282M	152.51%220M	-218.54%-1.96B	-158.89%-275M	-613.16%-390M	3.53%-874M
Minority interest income		102.19%7M	0	-97.87%1M		102.14%6M	-471.43%-320M	-1,550.00%-58M	487.50%47M	17.14%-29M
Net income attributable to the parent company	72.43%369M	186.03%1.41B	321.20%480M	199.08%433M	133.33%282M	253.96%214M	-193.20%-1.64B	-146.87%-217M	-733.33%-437M	2.98%-846M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	72.43%369M	186.03%1.41B	321.20%480M	199.08%433M	133.33%282M	253.96%214M	-193.20%-1.64B	-146.87%-217M	-733.33%-437M	2.98%-846M
Basic earnings per share	68.42%0.32	184.83%1.23	321.05%0.42	197.44%0.38	133.33%0.25	258.33%0.19	-190.00%-1.45	-146.34%-0.19	-750.00%-0.39	3.85%-0.75
Diluted earnings per share	72.22%0.31	183.45%1.21	315.79%0.41	194.87%0.37	132.00%0.24	250.00%0.18	-190.00%-1.45	-146.34%-0.19	-750.00%-0.39	3.85%-0.75
Dividend per share	0	0	0	0	0	0	0	0	0	0
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

No. Symbol 5D % Chg

Middle East conflict spreads to the stock market! How should investors respond?

According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm